Novocure had its Relative Strength (RS) Rating upgraded from 90 to 93 Wednesday. The cancer therapy stock soared almost 50% last week on positive news to an update from the late-stage study of its experimental lung cancer treatment. When you’re researching the best stocks to buy and watch, be sure to pay attention to relative price strength.
Read More
